Questcor Pharmaceuticals' P2P Acquisition

Questcor Pharmaceuticals raised a round of funding on August 15, 2014. Investors include Mallinckrodt.

Questcor Pharmaceuticals is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our specific areas of focus are in …

Articles about Questcor Pharmaceuticals' P2P Acquisition: